Announcements Trials
Browse Landscape

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Breast 1

Conditions

Ovarian Neoplasms 29Uterine Cervical Neoplasms 23Endometrial Neoplasms 14Breast Neoplasms 10Neoplasms 8Uterine Cervical Dysplasia 5Carcinoma, Ovarian Epithelial 5Peritoneal Neoplasms 4Papillomavirus Infections 4Lung Neoplasms 4Fallopian Tube Neoplasms 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Pancreatic Neoplasms 3Neoplastic Cells, Circulating 3Hereditary Breast and Ovarian Cancer Syndrome 3Disease 3Uterine Neoplasms 2Prostatic Neoplasms 2Primary Ovarian Insufficiency 2Ovarian Diseases 2Melanoma 2Leukemia 2Kidney Neoplasms 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Endometrial Hyperplasia 2Vulvar Neoplasms 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1

Interventions

Radiotherapy 10Cisplatin 9pembrolizumab 6Surveys and Questionnaires 6Methods 6Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 5fludarabine 4Papillomavirus Vaccines 4Early Intervention, Educational 4Cyclophosphamide 4Brachytherapy 4durvalumab 3aldesleukin 3Vaccines, Synthetic 3Vaccines 3Sentinel Lymph Node Biopsy 3Radiosurgery 3Radiation 3Platinum 3Palliative Care 3Paclitaxel 3Nivolumab 3Indocyanine Green 3Gemcitabine 3Drug Therapy 3Carboplatin 3Bleomycin 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3tremelimumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vulvar Neoplasms × Blood Specimen Collection × Gynecologic × Clear all
NCT03987555 2026-03-18

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Wake Forest University Health Sciences

Suspended
22 enrolled
BreastGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡